{"answers":{"affected":"It affects 1 product.","exploited":"There is no known exploitation of CVE-2015-3965 in the wild and no public exploit code.","fix":"No fix has been published for CVE-2015-3965 yet. Limit exposure of the affected software until one is available.","what":"CVE-2015-3965 is a high-severity vulnerability in Hospira Symbiq Infusion System, published on 23 Mar 2019. Any signed-in user can exploit it over the network, with no action from the victim."},"fix_prompt":"Check this codebase for CVE-2015-3965 and fix it if it is affected.\n\nWhat it is: CVE-2015-3965 is a high-severity vulnerability in Hospira Symbiq Infusion System, published on 23 Mar 2019. Any signed-in user can exploit it over the network, with no action from the victim.\nExploitation: There is no known exploitation of CVE-2015-3965 in the wild and no public exploit code.\n\nAffected product: Hospira Symbiq Infusion System. No package-level version data is available, so check the vendor advisory linked from the reference page.\n\nTask:\n1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.\n2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.\n3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.\n4. Run the tests and summarise what changed and why.\n5. If nothing in the project is affected, say so and change nothing.\n\nReference: https://insights.sbomify.com/CVE-2015-3965/ (Markdown: https://insights.sbomify.com/CVE-2015-3965/index.md)","id":"CVE-2015-3965","markdown":"https://insights.sbomify.com/CVE-2015-3965/index.md","name":"CVE-2015-3965","record":{"aliases":["GHSA-fw6x-q668-xp72"],"analysis":{"component_type":"ics_ot","fix_type":"no_fix_stated","impacts":["privilege_escalation","code_execution"],"network_reachable":"yes","non_default_config":false,"product_category":"Infusion System","requires_auth":"low_privilege","summary":"Remote authenticated users can escalate privileges to trigger unanticipated operations on Hospira Symbiq Infusion Systems.","user_interaction":"not_required","vuln_class":"privilege_escalation"},"analysis_generated_by":"qwen3.8-flash-next","assigner":"icscert","cpe":[{"product":"symbiq_infusion_system_firmware","vendor":"pfizer"}],"cvss":{"score":8.8,"severity":"high","source":"nvd","vector":"CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H","version":"3.0"},"cwes":[{"id":"CWE-264","name":null}],"description":"Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger \"unanticipated operations\" by leveraging \"elevated privileges\" for an unspecified call to an incorrectly exposed function.","ecosystems":[],"exploits":{"exploitdb":0,"first_seen":null,"github_poc":0,"max_poc_stars":null,"metasploit":0,"nuclei":0,"refs":[],"tier":"none_known"},"has_fix":null,"headline":"Privilege escalation in Symbiq Infusion System","id":"CVE-2015-3965","indexable":true,"kev":null,"kind":"cve","links":{"ecosystem":null,"product":null,"products":[],"type":"privilege_escalation","year":"2015"},"n_packages":0,"n_references":1,"next":{"headline":"Denial of service in n/a","id":"CVE-2015-3966"},"packages":[],"prev":{"headline":"Hardcoded credentials in n/a","id":"CVE-2015-3964"},"products":["Symbiq Infusion System"],"published":"2019-03-23","related":[],"sources":[{"class":"attribution","licence":"CVE Terms of Use (MITRE)","name":"CVE List","prefix":"CVE"},{"class":"attribution","licence":"US public information, NVD API terms","name":"NVD"},{"class":"attribution","licence":"CWE Terms of Use","name":"CWE (MITRE)"},{"class":"attribution","licence":"FIRST CVSS licence","name":"CVSS (FIRST)"}],"ssvc":{"automatable":null,"exploitation":null,"technical_impact":null},"state":"PUBLISHED","updated":"2024-08-06","vendors":["Hospira"]},"summary":"Remote authenticated users can escalate privileges to trigger unanticipated operations on Hospira Symbiq Infusion Systems.","url":"https://insights.sbomify.com/CVE-2015-3965/"}